Sword Health, a Portuguese medtech company, has raised $4.6 million in a seed round from Green Innovations and Vesalius Biocapital III. The Porto-based startup has developed an AI-enabled physiotherapy solution called Sword Phoenix for physical rehabilitation that harnesses data collected by sensors, which is monitored by remote physiotherapists. “Demand for physical rehabilitation therapy is rising […]
Israeli digital health company Nutrino has raised $8 million in a Series A round from Pereg Ventures, Nielsen Ventures, Gandyr Group, and a number of business angels. Nutrino develops data analytics tools for nutrition, mostly targeted at people with diabetes and uses AI and machine learning to better understand dietary impacts. It terms this data […]
Careship has raised €6 million in a funding round led by Creandum with participation from new and existing investors Ananda Ventures, Spark Capital, Atlantic Labs, and Axel Springer’s accelerator programme Plug and Play. The Berlin-based startup, founded by siblings Antonia and Nikolaus Albert, provides an online marketplace for elderly care services that’s powered by a […]
Diaceutics, an Irish medtech startup, has raised €4.3 million in mezzanine financing from WhiteRock Capital Partners and Capital Partners. Through this mezzanine funding round the investors have provided capital in the form of debt with the option to convert to equity. The Dundalk-based company develops data-driven diagnostics tools for the pharmaceutical and medical sectors, mostly […]
Belgian medtech startup UgenTec has raised €7.5 million from investment firm LRM, IMEC, KU Leuven Gemma Frisius Fund, KU Leuven, and biotech investors Annie Vereecken and Herman Verrelst. The startup develops software using AI, called FastFinder, for analysing polymerase chain reaction, a common method of analysing DNA for infectious diseases and in oncology. According to […]
VC firm Eight Roads Ventures Europe, the investment division of fund managers Fidelity International, has launched its new $375 million fund to invest in European and Israeli scaleups. Dubbed ERVE III, it is Eight Roads’ third Europe-focused venture fund and will address the increasing demands for funding for growth stage companies, the London-based firm said. […]
Acacia Pharma, which is developing treatments for surgical and cancer patients, this month listed on Euronext stock exchange in Brussels, raising €40 million.